| Literature DB >> 33539568 |
German Pozdeev1, Aalap Mogre1, Charles J Dorman1.
Abstract
DNA gyrase is an essential type II topoisomerase that is composed of two subunits, GyrA and GyrB, and has an A2 B2 structure. Although the A and B subunits are required in equal proportions to form DNA gyrase, the gyrA and gyrB genes that encode them in Salmonella (and in many other bacteria) are at separate locations on the chromosome, are under separate transcriptional control, and are present in different copy numbers in rapidly growing bacteria. In wild-type Salmonella, gyrA is near the chromosome's replication terminus, while gyrB is near the origin. We generated a synthetic gyrBA operon at the oriC-proximal location of gyrB to test the significance of the gyrase gene position for Salmonella physiology. Although the strain producing gyrase from an operon had a modest alteration to its DNA supercoiling set points, most housekeeping functions were unaffected. However, its SPI-2 virulence genes were expressed at a reduced level and its survival was reduced in macrophage. Our data reveal that the horizontally acquired SPI-2 genes have a greater sensitivity to disturbance of DNA topology than the core genome and we discuss its significance in the context of Salmonella genome evolution and the gyrA and gyrB gene arrangements found in other bacteria.Entities:
Keywords: zzm321990gyrAzzm321990; zzm321990gyrBzzm321990; DNA gyrase; DNA supercoiling; SPI-1; SPI-2; Salmonella enterica serovar Typhimurium
Mesh:
Substances:
Year: 2021 PMID: 33539568 PMCID: PMC8359277 DOI: 10.1111/mmi.14689
Source DB: PubMed Journal: Mol Microbiol ISSN: 0950-382X Impact factor: 3.501
FIGURE 1Construction of a derivative of S.Typhimurium strain SL1344 with a gyrBA operon. Chromosomal maps of the WT SL1344 and SL1344 gyrBA strains. Positions of oriC, dif, and chromosome macrodomains are shown. Promoter (angled arrow), protein‐coding region (open reading frame, ORF), and the terminator (stem‐loop structure) of the genes of interest are shown and color coded. The gyrA ORF is green and the gyrB promoter and ORF are red. Not to scale
FIGURE 2Minimum inhibitory concentrations of DNA gyrase‐inhibiting antibiotics in the wild‐type SL1344 and SL1344 gyrBA strains. Cells were grown in a 96‐well plate with 1:1.25 serially diluted antibiotics in LB broth for 18 hr at 37°C and aeration. Cell density was measured by OD600. (a) Percentage survival of the WT and SL1344 gyrBA in 65.54–160 μg/ml of novobiocin. MIC90 of the WT = 128 μg/ml, MIC90 of SL1344 gyrBA = 160 μg/ml. (b) Percentage survival of the WT and the gyrBA in 2.62–8 μg/ml of coumermycin, MIC90 = 6.4 μg/ml. (c) Percentage survival of the WT and the gyrBA in 1.31–3.2 μg/ml of nalidixic acid, MIC90 = 2.56 μg/ml. (D) Percentage survival of the WT and the gyrBA in 0.0084–0.0205 μg/ml of ciprofloxacin, MIC90 = 0.0164 μg/ml. Error bars represent the standard deviation of at least three biological replicates. Significance was found by unpaired Student's t‐test, where * = p < .05 and ** = p < .01
FIGURE 3Motility and competitive fitness of strain SL1344 gyrBA. (a). Diameters of swimming motility were measured after 5 hr incubation at 37°C on soft 0.3% LB agar. The gyrBA strain is slightly, but statistically significantly, less motile than the WT. Values below 1 indicate that the strain is less motile than the WT. (b) Fitness of the gyrBA strain was compared to the WT SL1344 in LB broth grown for 24 hr with aeration at 37°C. Fitness index (f.i.) = 1 means that the competed strains were equally fit, f.i. ˂ 1 indicates that the competitor strain is less fit than the WT, f.i. ˃ 1 indicates that the competitor is more fit than the WT. The gyrBA and the WT were equally fit. Significance was determined by one‐sample T‐test, where p < .05
FIGURE 4Expression of the gyrA and gyrB genes in wild‐type SL1344 (WT) and SL1344 gyrBA during growth in liquid culture. Cells were grown in LB broth at 37°C with aeration and samples were taken at 2 hr, 3.5 hr, 5 hr, and 7 hr representing the lag, exponential, exponential‐stationary transition, and early stationary phases of growth, respectively. Transcription of gyrA and gyrB was measured and is reported relative to that of the hemX reference gene. Three biological replicates were used. Statistical significance was found by unpaired Student’s T‐test, where p < .05
FIGURE 5Reporter plasmid DNA supercoiling in SL1344 gyrBA. The pUC18 reporter plasmid was extracted from the WT and the SL1344 gyrBA strains at the stationary phase of growth and electrophoresed on a 0.8% agarose gel containing 2.5 μg/ml of chloroquine. The arrow shows the direction of migration, with the more supercoiled plasmid topoisomers at the right of the gel. (a). Global DNA supercoiling pattern of the WT and the gyrBA strain when grown in LB. (b). Global DNA supercoiling pattern of the WT and the gyrBA strain when grown in minimal medium N with high (10 mM) MgCl2 or low (10 μM) MgCl2. Sample lanes are supplemented with densitometry profiles that were generated with ImageJ. The analysis is representative of four biological replicates
FIGURE 6Expression of genes in the SPI‐1 and SPI‐2 pathogenicity islands in wild‐type SL1344 (WT) and SL1344 gyrBA. Expression of gfp reporter gene fusions was measured in the wild‐type and SL1344 gyrBA strains every 20 min over a 24‐hr. period. (a). SPI‐1 expression in the gyrBA strain was identical to that in the WT in LB. (b). SPI‐2 expression in the gyrBA strain was identical to that of the WT in LB. (c). SPI‐1 expression in minimal medium N with high MgCl2 concentration (10 mM) was repressed in both the WT and the gyrBA strain. (d). SPI‐2 expression in minimal medium N with high MgCl2 concentration was repressed in both the WT and the gyrBA strains. (e). SPI‐1 expression in minimal medium N with a low MgCl2 concentration (10 µM) was repressed in both the WT and the gyrBA strains. (F) SPI‐2 expression in minimal medium N with low MgCl2 concentration was lower in the gyrBA strain than in the WT at the stationary phase of growth. All plots are the results of at least three biological replicates; error bars represent the standard deviation. Statistical significance was found by Student's unpaired T‐test, where p < .05
FIGURE 7SPI‐1‐mediated entry and survival of the WT and SL1344 gyrBA strain in cultured RAW264.7 macrophage cells. Cells were infected with SPI‐1‐induced bacteria, grown to mid‐exponential phase to promote SPI‐1‐mediated invasion. Survival and replication were measured by enumerating colony‐forming units (CFUs) at 3 hr, 8 hr, 16 hr, and 20 hr post‐infection. Fold replication represents the number of CFUs recovered at a particular time point divided by the CFU number at 1 hr. Mean and individual replicates are shown. Significance at 16 hr was found by unpaired Student's T‐test, where p < .05
Relative positions of gyrB and gyrA across bacterial species
| Organism (phylum, lowest clade sharing the arrangement) | ||||
|---|---|---|---|---|
| Group 1 ( | ||||
|
| 45,409, Right | 0.98 | 1,585,679, Right | 34.20 |
| 42,033, Left | 0.86 | 1,730,509, Left | 35.48 | |
| 37,634, Right | 0.81 | 1,382,662, Left | 29.68 | |
|
| 57,368, Left | 1.25 | 1,577,518, Left | 34.24 |
|
| 37,176, Left | 0.79 | 1,073,028, Right | 22.82 |
|
| 10,386, Right | 0.35 | 1,329,436, Right | 44.90 |
|
| 2,248, Right | 0.04 | 2,708,909, Left | 43.26 |
| 3,161, Right | 0.06 | 1,876,940, Right | 36.27 | |
| 179,561, Left | 5.42 | 1,595,259, Right | 48.17 | |
| 166,112, Right | 4.14 | 1,744,542, Right | 43.43 | |
| 32,299, Right | 0.61 | 1,182,414, Left | 22.49 | |
| 160,154, Right | 4.62 | 859,834, Left | 24.82 | |
| 635, Right | 0.04 | 653,170, Left | 40.12 | |
| Group 2 ( | ||||
| 310,304, Right | 3.40 | 872,133, Right | 9.54 | |
| 246,107, Right | 3.93 | 2,199,265, Left | 35.10 | |
| 155,636, Right | 2.99 | 2,420,574, Left | 46.50 | |
| 382,412, Left | 34.40 | 250,129, Right | 22.50 | |
| 412,632, Left | 19.16 | 616,174, Right | 28.61 | |
| 786,742, Left | 37.25 | 951,471, Right | 45.05 | |
| 521,569, Left | 27.53 | 897,992, Right | 47.40 | |
| 448,681, Left | 14.19 | 1,240,595, Right | 39.22 | |
| 267,997, Left | 12.64 | 697,114, Right | 32.89 | |
| 2,928,149, Right | 47.03 | 2,182,864, Left | 35.06 | |
| 552,805, Left | 23.59 | 873,251, Left | 37.26 | |
| 911,819, Right | 34.45 | 714,641, Left | 26.88 | |
| 685,949, Right | 16.62 | 33,951, Left | 0.82 | |
| Group 3 ( | ||||
| 1831, Right | 0.05 | Downstream of | ||
| 2057, Right | 0.06 | downstream of | ||
| 3,994, Left | 0.05 | downstream of | ||
| 2,643, Right | 0.06 | downstream of | ||
| 2,843, Right | 0.11 | downstream of | ||
| 2,472, Left | 0.09 | downstream of | ||
| 2,557, Right | 0.11 | downstream of | ||
| 5,883, Right | 0.20 | downstream of | ||
| 3,776, Right | 0.13 | downstream of | ||
| 2,546, Right | 0.06 | downstream of | ||
| 941, Left | 0.38 | downstream of | ||
| 3,170, Left | 0.15 | downstream of | ||
| 1,268, Left | 0.14 | downstream of | ||
| 33,798, Right | 2.94 | downstream of | ||
| Group 4 ( | ||||
| 573,957, Left | 48.97 | downstream of | ||
| 504,740, Left | 48.42 | downstream of | ||
| 1,044,601, Right | 49.36 | downstream of | ||
*Where gyrB and gyrA form an operon, gyrA is universally located downstream of gyrB.
FIGURE 8Phylogenetic tree of bacteria that belong to different groups based on their gyrA and gyrB arrangement. The phylogenetic tree was built in phyloT, a phylogenetic tree generator based on NCBI taxonomy (Letunic & Bork, 2019). Each of the four groups (see Table 1) of gyrA and gyrB arrangements is indicated by color. Group 1, blue: gyrA and gyrB are at separate locations, with a conserved genetic environment 5' to gyrB. Group 2, orange: gyrA and gyrB are at separate locations, with a non‐conserved genetic environment 5' to gyrB. Group 3, green: gyrBA operon, conserved genetic environment 5' to gyrB. Group 4, red: gyrBA operon, non‐conserved genetic environment 5' to gyrB. Phyla names are indicated
Bacterial strains
| Strain name | Genotype/Description | Source/reference |
|---|---|---|
| SL1344 |
| Hoiseth and Stocker ( |
| SL1344 | Kanamycin resistance cassette inserted downstream of the | This work |
| SL1344 | Kanamycin resistance cassette inserted downstream of the | This work |
| SL1344 | This work | |
| SL1344 | Ibarra et al. ( | |
| SL1344 | Fusion of a | This work |
| SL1344 | Ibarra et al. ( | |
| SL1344 | Fusion of a | This work |
| SL1344 | Insertion of a chloramphenicol resistance cassette into the pseudogene | This work |
| SL1344 | Insertion of a chloramphenicol resistance cassette into the pseudogene | This work |
Plasmids used in this study
| Plasmid name | Description | Reference |
|---|---|---|
| pKD3 | AmpR (CarbR), CmR | Datsenko and Wanner ( |
| pKD4 | AmpR (CarbR), KanR | Datsenko and Wanner ( |
| pKD46 | AmpR (CarbR), λ Red genes | Datsenko and Wanner ( |
| pCP20 | AmpR (CarbR), CmR, FLP recombinase expressing, temperature‐sensitive replicon | Cherepanov and Wackernagel ( |
| pUC18 | AmpR (CarbR) | Yanisch‐Perron et al. ( |
Abbreviations: AmpR (CarbR), ampicillin (carbenicillin) resistance; CmR, chloramphenicol resistance; KanR, kanamycin resistance.